Cypher AI and Flock Bio Partner to Accelerate Pooled DNA Library Innovation With AI-Native Platform
Cambridge, MA & San Francisco, CA — Dec 1, 2025
Cypher AI, the AI-native software infrastructure platform for biotechnology R&D, today announced an expanded collaboration with Flock Bio, a fast-growing provider of high-quality, customizable pooled DNA libraries. Flock Bio has officially joined the Cypher Startup Program, gaining access to Cypher’s end-to-end protocol automation engine, integrated customer order management system, and automated data pipelines.
The two companies began working together last month, and the impact has already exceeded expectations.
Based in the San Francisco Bay Area, Flock Bio specializes in delivering reliable, fast, and highly customizable pooled DNA libraries built for the demanding needs of high-throughput molecular biology. Every library is backed by full NGS quality control with multiple sequencing configurations to ensure accuracy, reproducibility, and robust downstream performance. By partnering with a broad network of DNA synthesis providers, Flock Bio offers unmatched flexibility in DNA formats and capabilities, helping researchers accelerate timelines while avoiding common pitfalls in pooled library construction.
Cypher AI provides biotech companies with end-to-end digital infrastructure that replaces manual workflows with AI-native automation. The platform transforms scientific protocols into step-by-step executable tasks, orchestrates experiments through partner labs, centralizes data processing through automated analysis pipelines, and provides a unified customer order management system for CRO-style service delivery. Through the Cypher Startup Program, early-stage biotech companies receive discounted access to Cypher’s protocol engine, analysis tools, data dashboards, and managed partner-lab network.
“Flock Bio is setting new standards in pooled DNA library quality and turnaround time,” said Yaoyu Yang, Founder & CEO of Cypher. “By combining their operational excellence with Cypher’s protocol automation, ordering workflows, and data infrastructure, we’re enabling researchers to go from design to results faster than ever before.”
Matthew Youngblut, CSO of Flock Bio, emphasized the value seen immediately since the collaboration began: “We started working with Cypher just a month ago, and the value is already off the charts. This is the platform I’ve wanted my entire career. The automation, the data pipelines, and the order management, it all just works. It lets our team focus on delivering the highest-quality libraries while giving our customers a level of visibility and reproducibility we simply couldn’t achieve before.”
Through this collaboration, Flock Bio will leverage Cypher’s AI-driven protocol builder, automated QC and reporting workflows, integrated dashboards, and cloud-scale data processing. The combined strengths of both companies will deliver faster turnaround times, deeper insights, and a more seamless customer experience for scientists working in high-throughput molecular biology.
Together, Cypher AI and Flock Bio are lowering the operational barriers to high-throughput biology and pooled DNA library workflows, helping researchers generate higher-quality data, faster.
About Cypher
Cypher is an AI-powered platform built for supercharging scientific research. Designed to streamline protocol creation, data analysis, visualization, and team collaboration, Cypher enables research groups to run better experiments and accelerate discovery. Whether you’re in biotech, pharma, or academia, Cypher gives your team the tools to significantly reduce repetitive, low-scientific-value tasks and focus on what matters most to science. Built by scientists for scientists.
Learn more at: https://cypherbio.ai
About Flock Bio
Flock Bio is a biotechnology startup based in the San Francisco Bay Area specializing in high-throughput, customizable pooled DNA libraries. Built for the demands of modern molecular biology, Flock Bio delivers consistently high-quality libraries backed by full NGS quality control with multiple sequencing options to ensure accuracy and reproducibility. By partnering with a broad network of DNA synthesis providers, Flock Bio offers an unmatched range of DNA formats and tailored capabilities, helping researchers accelerate timelines while maintaining scientific rigor. With streamlined operations and a commitment to operational excellence, Flock Bio enables scientists to avoid common pitfalls in library construction and focus on generating meaningful experimental data.
Learn more at: https://flockbio.com